Treatment for moderately to severely active ulcerative colitis Research study
A clinical trial to assess whether guselkumab and golimumab when used together is safe and effective for treating participants with moderately to severely active ulcerative colitis (UC).
https://www.thermh.org.au/research/clinical-trials-research-studies/treatment-for-moderately-to-severely-active-ulcerative-colitisWe provide several specialised services, including immune deficiency diagnosis and allergy challenge testing.
https://www.thermh.org.au/services/immunology-allergy/specialised-servicesA clinical trial is a scientific study of a new medication or device that involves human volunteers. Clinical trials are a test of the effectiveness of the new treatment and how safe it is. Clinical trials are also used to find new uses for existing medicines.
https://www.thermh.org.au/research/about-clinical-trialsThe RMH Neurology Fellow wins Stephen Davis Award News article
The RMH Neurology Fellow Dr Izanne Roos has been awarded The Stephen Davis Award for Outstanding Fellow of the Year.
https://www.thermh.org.au/news/the-rmh-neurology-fellow-wins-stephen-davis-awardWe partner with the University of Melbourne to undertake clinical teaching and research in mental health.
https://www.thermh.org.au/services/mental-health/our-researchThis step of the job application pack explains how to use your cover letter to introduce yourself to the recruitment manager and indicate why you’re a strong match for the role.
https://www.thermh.org.au/health-professionals/careers/current-vacancies/first-nations-careers/job-application-pack/write-your-cover-letterJames Beaney: an eccentric surgeon from our past
James Beaney was a surgeon at the Melbourne Hospital from 1860 to 1891. His every step invited controversy and divided public opinion.
https://www.thermh.org.au/about/about-the-rmh/our-history-and-archives/james-beaney-an-eccentric-surgeon-from-our-pastNarcolepsy is a rare neurological disorder where the part of the brain that controls falling asleep functions abnormally.
https://www.thermh.org.au/services/respiratory-medicine-sleep-disorders/learn-about/sleep-studies-and-disorders/narcolepsyAllergic diseases are common and are increasing in prevalence. We diagnose and manage the following allergic diseases.
https://www.thermh.org.au/services/immunology-allergy/allergic-diseasesDeferiprone as a treatment for Alzheimer’s disease Research study
A clinical trial to investigate whether deferiprone delays dementia progression in the early stages of dementia.
https://www.thermh.org.au/research/clinical-trials-research-studies/deferiprone-as-a-treatment-for-alzheimers-diseaseNeural mechanisms of ketamine antidepressant treatment Research study
The NeuroKet study aims to understand how ketamine works as an antidepressant medication. To find out, we are looking at brain activity using Magnetic Resonance Imaging (MRI) scans.
https://www.thermh.org.au/research/clinical-trials-research-studies/neural-mechanisms-of-ketamine-antidepressant-treatmentManaging latent tuberculosis in general practice and community settings
Latent tuberculosis infection (LTBI) is an asymptomatic condition that may progress to active tuberculosis (TB), sometimes decades after exposure.
https://www.thermh.org.au/services/victorian-tuberculosis-program/about-vtp/managing-ltbi-in-general-practice-community-settingsRMH experts demonstrate benefits of virtual stroke care in groundbreaking research News article
An international team of stroke experts from Australia’s first Mobile Stroke Unit (MSU) have proven an innovative, virtual way of delivering care can provide outcomes that are just as good as in-person, saving time and lives.
https://www.thermh.org.au/news/rmh-specialists-demonstrate-benefits-of-virtual-stroke-care-in-groundbreaking-researchNew add-on therapy to infliximab for ulcerative colitis Research study
A clinical trial to assess the effectiveness of a new add-on therapy (PF-06687234) to infliximab.
https://www.thermh.org.au/research/clinical-trials-research-studies/new-add-on-therapy-to-infliximab-for-ulcerative-colitisSwabs required for research to develop point-of-care testing for infectious diseases Research study
ZiP Diagnostics requires human samples for research into developing point-of-care (PoC) diagnostic tests for a range of infectious diseases.
https://www.thermh.org.au/research/clinical-trials-research-studies/research-to-develop-point-of-care-testing-for-infectious-diseasesMeg reunited with paramedics after 100 days at the RMH News article
Former patient Meg was reunited with the paramedics who helped save her life.
https://www.thermh.org.au/news/meg-reunited-with-paramedics-after-100-days-at-the-rmhCouple both diagnosed with leukaemia marry in special ceremony News article
Leukaemia patients Pat and Trish married last week.
https://www.thermh.org.au/news/couple-both-diagnosed-with-leukaemia-marry-in-special-ceremonyWe are committed to evidence-based best practice, continuous quality improvement and teaching.
https://www.thermh.org.au/services/anaesthesia-pain-management/anaesthesia-clinical-initiativesBI 456906 for non-alcoholic steatohepatitis (NASH) and liver fibrosis Research study
A study to test whether different doses of BI 456906 are effective in people with a liver disease called non-alcoholic steatohepatitis (NASH) and liver fibrosis.
https://www.thermh.org.au/research/clinical-trials-research-studies/bi-456906-for-non-alcoholic-steatohepatitis-nash-and-liver-fibrosisA hard act to swallow – how Greg bounced back from a stroke of misfortune News article
Greg suffered a major stroke in late 2022, something he understatedly describes as an ‘interesting experience’.
https://www.thermh.org.au/news/a-hard-act-to-swallow-how-greg-bounced-back-from-a-stroke-of-misfortune